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is a goal shared by many partners who serve the children
of our country and certainly is a priority for Medicaid
and the Children’s Health Insurance Program (CHIP) in
every state. There are few tools to measure quality of
care, especially for children, and mechanisms to compare
the quality of children’s health care services across states,
programs, delivery systems, etc, are lacking. The inclusion
of a section on the quality of children’s health care in the
Children’s Health Insurance Program Reauthorization
Act (CHIPRA)1 has caused excitement among those
working on health care improvement and the measurement
of quality and improvement. This is a step in the right
direction in moving the vision for improved health care
quality and improved health status for all children closer
to becoming a reality.
The CHIPRA initial core set of quality measures is the
beginning of a discussion to determine which children’s
quality measures states will be reporting on in the future
for Medicaid and CHIP enrollees. This, along with other
activities outlined in CHIPRA, will provide further input
and opportunities to refine how states measure children’s
health care quality. The work of the Subcommittee on
Quality Measures for Children’s Healthcare in Medicaid
and CHIP, following the criteria set out in legislation and
narrowing down an extensive list of measures, is a starting
point. It is important to stress that these are the initial
measures and that a mechanism for ongoing review of
the measures and an evaluation of whether the measures
continue to be relevant for Medicaid and CHIP will be
necessary. Technology changes as do medical priorities,
and we must recognize that what may be relevant to
measure in 2010 may not be so relevant in 2 to 3 years.
It is essential that the core measures be flexible enough
to accommodate the uniqueness of each state’s Medicaid
and CHIP programs. Although the measures seem to be
applicable in each state, until the first round of measure-
ment is collected and reported, it is hard to tell how the
differences in state operations may impact the outcomes.
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to be useful and informative, it is essential that these
program differences be clearly articulated. This provides
a rationale for incorporating ongoing evaluations, not just
of the results and outcomes generated by the voluntary
reports but evaluations of the measures themselves and
what can be gleaned from measurements that seemed to
be a good idea on paper but whose outcomes did not
provide any useful results.
With so much activity underway, it is easy to become
excited as the core set of children’s quality measures acts
as a catalyst for a broad discussion on the quality of chil-
dren’s health care. At the same time, this set presents
many challenges to states. States will be faced with an
increase in program administration costs at a time when
new funding for states is very limited. Although Congress
had the foresight to include an enrollment performance
bonus process for states with increased CHIP andMedicaid
enrollment, there is no similar mechanism available to
states for improving the quality of children’s health care.
Second, there is the potential for duplicate reporting by
states on the same areas, at a time when everyone (health
plans, governments, providers, etc) is trying to reduce
administrative costs.
The introduction of the CHIPRA core measure set
comes at a time when states are looking for assistance in
the identification of measures to meet a number of require-
ments related to health care quality improvement created
by the flurry of activity resulting from the passage of addi-
tional federal legislation, the American Recovery and
Reinvestment Act (ARRA).2 The need for collaboration
at the federal level on the use of the CHIPRA core measure
set when and wherever feasible will aid in its adoption by
states. At a time when states are struggling with budget
shortfalls resulting in budget cuts and reduced manpower,
introducing multiple measure sets from different agencies
will ensure that adoption is hindered and uptake is limited.
Although the CHIPRA core measure set addresses the need
for consistency that many states have asked for, the failure
of federal collaboration on its use in health careVolume 11, Number 3S
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health care reform, etc) will result in the limited usefulness
of this set of measures. In addition, states should pursue the
usefulness of these measures within other activities related
to health care quality, such as shared savings or pay for
performance and provider and patient incentive programs.
The impact of the use of these measures should be assessed
on care decisions through collaboration with providers and
other stakeholders, followed by a discussion and consider-
ation of how the changes in care might impact policy
changes surrounding coverage decisions and payment
structure.
Although not perfect, the CHIPRA core measure set
should enhance the ability of all states to develop cohesive,
quality measurement programs through the provision of
actionable information that has the potential to improve
health care outcomes. Being strictly voluntary, the
CHIPRA core measure set should be considered just the
beginning. We will need to revisit and refine it to ensure
that a final set of measures is developed and utilized,
taking into consideration differing program and delivery
system designs so that data are collected and reported
that will allow for accurate comparisons of quality betweenstates. The hope is that states will use this as an opportunity
to test these measures so that maximum quality improve-
ment can be achieved and result in attainment of the
ultimate goal of improved health care outcomes for all
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